Enzymatic cleavage of specific dipeptide conjugated with ferrocene as a flexible ultra-sensitive and fast voltammetric assay of matrix metalloproteinase-9 considered a prognostic cancer biomarker in plasma samples
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 195, 113653
Abstract
No abstract availableKeywords
Funding Information
- Narodowe Centrum Nauki
This publication has 57 references indexed in Scilit:
- Mapping of matrix metalloproteinase cleavage sites on syndecan‐1 and syndecan‐4 ectodomainsThe FEBS Journal, 2013
- Extracellular Matrix Degradation and Remodeling in Development and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probesNature Medicine, 2009
- Advances in assays of matrix metalloproteinases (MMPs) and their inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry, 2008
- Chemiluminescent Probe for the in Vitro Detection of Protease ActivityOrganic Letters, 2007
- Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patientsInternational Journal of Cancer, 2003
- Matrix metalloproteinases in tumor–host cell communicationDifferentiation, 2002
- A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and PhosphatasesASSAY and Drug Development Technologies, 2002
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium SaltsHelvetica Chimica Acta, 1973
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963